Form 4: USANA Health Sciences Officer, David Mulham, Reports Stock Sale

David Mulham, Chief Sales Officer of USANA Health Sciences, reports the sale of 3,234 shares of common stock at an average price of $32.9839 on March 10, 2025.

Summary

• On March 10, 2025, David Mulham, the Chief Sales Officer of USANA Health Sciences, sold 3,234 shares of the company's common stock.
• The sale was executed at a weighted average price of $32.9839 per share.
• The price range for the multiple transactions was between $32.97 and $33.01 inclusively.
• Following the reported transaction, Mulham directly owns 12,775 shares of USANA Health Sciences.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of stock sales by an officer. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity, which is common among corporate officers. It provides transparency to the market regarding the buying and selling of company stock by its executives.

Stakeholder Impact

• The sale of shares by a company officer can sometimes be perceived negatively by shareholders, but it is a common occurrence and doesn't necessarily indicate a lack of confidence in the company.

Key Dates